We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Neuronal Identity Established by Specific Transcription Factors

By LabMedica International staff writers
Posted on 21 May 2018
Print article
Image: Human induced neurons generated from a novel transcription factor pair. Colors represent a nuclear stain (DAPI) in blue, synaptic marker expression (Synapsin1) in green, and neuron-specific beta-III tubulin expression (Tuj1) in red (Photo courtesy of Dr. Kristin Baldwin, The Scripps Research Institute).
Image: Human induced neurons generated from a novel transcription factor pair. Colors represent a nuclear stain (DAPI) in blue, synaptic marker expression (Synapsin1) in green, and neuron-specific beta-III tubulin expression (Tuj1) in red (Photo courtesy of Dr. Kristin Baldwin, The Scripps Research Institute).
A team of neurodegenerative disease researchers has developed a protocol for the consistent transformation of stem cells of fibroblast origin into specific classes of neurons for brain research and drug development.

Transient expression of certain transcription factors has been found to endow non-neural cells with neuronal properties. The relationship between reprogramming factors and the transcriptional networks that produce neuronal identity and diversity remains largely unknown.

To study this process, investigators at The Scripps Research Institute (La Jolla, CA; USA) screened 598 pairs of transcription factors in a mouse model system.

They reported in the May 9, 2018, online edition of the journal Nature that 76 pairs of transcription factors (12.7%) induced mouse fibroblasts to differentiate into cells with neuronal features. By comparing the transcriptomes of these induced neuronal cells (iN cells) with those of natural neurons, the investigators defined a "core" cell-autonomous neuronal signature. The iN cells also exhibited diversity; each transcription factor pair produced iN cells with unique transcriptional patterns that could predict their pharmacological responses. By linking distinct transcription factor input "codes" to defined transcriptional outputs, these findings delineated cell-autonomous features of neuronal identity and diversity and expanded the reprogramming toolbox to facilitate engineering of induced neurons with desired patterns of gene expression and related functional properties.

"The brain is incredibly complex, with thousands of different types of cells that are each involved in different diseases," said senior author Dr. Kristin Baldwin, a professor at the Scripps Research Institute. "The problem with understanding and treating the many disorders of the brain is that we cannot reproducibly produce the right types of brain cells. Now we have found more than 75 new ways to rapidly and reproducibly turn skin cells into neurons that we think will be much better representatives of different neurologic diseases than were previously available. Having a personalized and nearly unlimited supply of different types of neuronal cells in a dish lets you uncover what is going wrong in a disease. At the same time, the study supplies a new toolkit to test thousands of drugs on the affected cells to try to reverse the problems, rather than having to test them in mice or other animals, with results that are often difficult to interpret for human conditions."

Related Links:
The Scripps Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.